CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | +50.0% | 1,000 | +1023.6% | 0.00% | – |
| Q2 2018 | $4,000 | -20.0% | 89 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -16.7% | 89 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | -81.2% | 89 | -77.4% | 0.00% | – |
| Q3 2017 | $32,000 | +60.0% | 394 | +85.8% | 0.00% | – |
| Q2 2017 | $20,000 | -31.0% | 212 | -67.0% | 0.00% | – |
| Q4 2016 | $29,000 | -58.0% | 642 | -66.5% | 0.00% | -100.0% |
| Q3 2016 | $69,000 | – | 1,917 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |